NEW YORK ( F.A.S.T. Graphs) -- Affordable health care is a huge problem for America, and the jury is still out on whether the Affordable Healthcare Act, aka, Obamacare is a blessing or curse.
Regardless, I believe AmSurg Corp ( AMSG) is part of the solution, and therefore poised to prosper. AmSurg is a growth stock that is currently trading at a sound valuation. Based on fundamentals, AmSurg Corp is very attractively priced today. The following earnings and price correlated F.A.S.T. Graphs (the orange line plots earnings, the black line price), reveals the stock is currently trading at a low valuation relative to its historical norms.AmSurg acquires, develops and operates ambulatory surgery centers in partnership with physicians. Headquartered in Nashville, Tenn., AmSurg operated 228 ambulatory surgery centers at Dec. 31, 2011. By focusing on the delivery of high-quality, low-cost surgery services that create high patient and physician satisfaction, AmSurg creates value for the three constituencies involved in every surgical procedure: the patient, the physician and the payor.According to Christopher A. Holden, president, CEO and director, speaking to the Barclays Global Healthcare Conference on March 13, health-care reform is a net positive for the company's long-term growth and profitability. He reported that over the last three decades there's been a paradigm shift where the vast majority of all surgery is performed on an outpatient basis.
